Garrett Baldwin discusses the indicators that tell us we're in a recession, regardless of whether or not officials acknowledge it.
The New Normal Is Here – and It Can Double Your Money Right Now
Shah Gilani picks out two healthcare-related options plays that are set to provide double or more returns.
Three Stocks to Sell and One to Buy
Shah Gilani's got three stocks to sell immediately and one great stock to buy.
The One mRNA Vaccine Stock to Buy Today
Pfizer, BioNTech, and Moderna investors enjoyed massive gains from late 2020 to early 2021 as the "vaccine stocks" exploded in value as their product was authorized.
Here's the thing, though – the profits aren't finished.
One company is set to experience another round of big gains over the next year or more.
Michael A. Robinson has the ticker…
Why the Dow Jones Could Quickly Hit 35,000
The anticipation is palpable… and building fast. We've had three reports on extremely effective upcoming coronavirus vaccines, and each report practically blows the last one out of the water.
First we heard preliminary reports that Pfizer and BioNTech's revolutionary messenger RNA (mRNA) coronavirus vaccine was 90% effective. That was great… until yesterday morning, when the biotechs got back in touch to say the real figure was something closer to 95%. And in the middle, we've heard from Moderna, which is reporting its mRNA vaccine is 94.5% effective.
Every time, stocks have taken off like a shot at the news; vaccines have helped push the Dow back above its February 2020 highs.
Here's the thing… setting aside the six vaccines The New York Times reports are in limited use in China and Russia – about which there are many unanswered questions – there are at least nine more coronavirus vaccines deep in phase 3, large-scale efficacy trials.
And there are no less than 55 more candidates in earlier, phase 1 and 2 trials. Some of these vaccine candidates won't advance, but others almost certainly will – two have already.
That all this has happened in less than a year is an "Apollo moonshot"-like scientific achievement. But that's also a whole lot of concentrated upside potential that could flood the markets and push stocks to almost unthinkable highs.
So I asked Money Morning Chief Investment Strategist Shah Gilani what it all means for us investors…
How to Trade Pfizer Stock for a 290% Profit in a Month
Pfizer's recent news that their COVID-19 vaccine is 90% effective sent the market (and Pfizer's stock) soaring.
And while those who had already invested in the stock have made a nice return, Tom's going to show you the quick and easy way to almost quadruple your money on it…
The COVID-19 Vaccine Stocks to Buy Right Now
The markets have gone ballistic on positive news of a COVID-19 vaccine, but investors are buying in all the wrong places.
Here are the best COVID-18 vaccine stocks to buy…